HSDT

Helius Medical Technologies, Inc. [HSDT] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

HSDT Stock Summary

Top 10 Correlated ETFs

HSDT

Top 10 Correlated Stocks

HSDT

In the News

HSDT Financial details

Company Rating
-
Market Cap
5.47M
Income
-7.43M
Revenue
644K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
22
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-0.38
Forward P/E
-
PEG
0.05
P/S
6.95
P/B
1.72
P/C
-
P/FCF
-0.52
Quick Ratio
4.99
Current Ratio
5.98
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-11.79
EPS next Y
-
EPS next Q
-
EPS this Y
-68.7%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-15.51%
Revenue Q/Q
-6.29%
EPS Q/Q
-73.22%
-
-
-
-
SMA20
-23.68%
SMA50
-74.24%
SMA100
-53.63%
Inst Own
-
Inst Trans
-
ROA
-153%
ROE
-249%
ROC
-1.73%
Gross Margin
19%
Oper. Margin
-1623%
Profit Margin
-1715%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.29-14.45
52W High
-75.89%
52W Low
-15.63%
RSI
34.4
Rel Volume
0.97
Avg Volume
417.25K
Volume
405.94K
Perf Week
-18.87%
Perf Month
-43.56%
Perf Quarter
-79.29%
Perf Half Y
-93.92%
-
-
-
-
Beta
1.553
-
-
Volatility
0.26%, 0.73%
Prev Close
-5.46%
Price
3.375
Change
-9.27%

Something similar

Top by Market Cap
VFINX
MSFT
NVDA
JPM
LLY.SW
Top Correlated ETFs
KGRN
BTC
MAXI
DEFI
IBIT
Top Correlated Stocks
PDD
SBFM
1AT.WA
IEP
MYSZ
Similar Market Cap
SC06.DE
RY8.DE
LIDR
TDCB
CYCN

Company Profile

Healthcare Medical - Devices
  • Volume Average 417.25K
  • Market Capitalization 5.47M
  • Employee 22
  • CEO Mr. Dane Carl Andreeff
  • Headquarters Newtown,PA,US
  • IPO Date 2014-06-27
  • Website https://heliusmedical.com

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.